Stockscreener 앱 받기
0.4027
0.67%
0.0027
시간 외 거래:
.39
-0.0127
-3.15%
Aethlon Medical Inc 주식(AEMD)의 최신 뉴스
Aethlon Medical (NASDAQ:AEMD) Earns Sell Rating from Analysts at StockNews.com - Defense World
AEMD: Aethlon Medical Unveils Study on Innovative Blood Filtrati - GuruFocus
Aethlon Medical Announces Publication of Preclinical Data Showin - GuruFocus
Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma - Yahoo Finance
Aethlon Medical Approves Key Stockholder Proposals - TipRanks
Comparing Paragon 28 (NYSE:FNA) and Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com - Defense World
StockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Significant Decline in Short Interest - Defense World
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com - Defense World
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com - Defense World
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Virtu Financial LLC Buys Shares of 94,173 Aethlon Medical, Inc. (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 46.7% in March - Defense World
Aethlon Medical at Emerging Growth Virtual Conference: Oncology Focus and Financial Strategy - Investing.com
Aethlon Medical (NASDAQ:AEMD) & Nephros (NASDAQ:NEPH) Head to Head Comparison - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by StockNews.com - Defense World
Aethlon Medical issues new warrants, modifies rights By Investing.com - Investing.com Australia
Aethlon Medical issues new warrants, modifies rights - Investing.com
Short Interest in Aethlon Medical, Inc. (NASDAQ:AEMD) Drops By 52.0% - Defense World
HC Wainwright Reiterates Buy Rating for Aethlon Medical (NASDAQ:AEMD) - The AM Reporter
Aethlon Medical’s (AEMD) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Buy Rating for Aethlon Medical Driven by Hemopurifier’s Potential in Organ Transplantation and Projected Growth - TipRanks
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal - Investorideas.com newswire
Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal - Yahoo Finance
Aethlon Medical, Inc. to Host Earnings Call - ACCESS Newswire
Investor Network: Aethlon Medical, Inc. to Host Earnings Call - ACCESS Newswire
HC Wainwright Boosts Earnings Estimates for Aethlon Medical - Defense World
Aethlon Medical (NASDAQ:AEMD) Receives “Buy” Rating from HC Wainwright - Defense World
Aethlon Medical (NASDAQ:AEMD) Raised to Sell at StockNews.com - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 21.3% in January - Defense World
Aethlon Medical strengthens oncology trial with protocol updates and cost reductions - MSN
Aethlon Medical IncThe company expects to conduct a capital raise that - Smartkarma
Aethlon’s Earnings Call: Trials and Cost Strategies - TipRanks
Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2025 Earnings Call Transcript - Insider Monkey
Live Investor Update: Aethlon Medical Unveils Latest Cancer Treatment ProgressCEO Takes Questions - StockTitan
Aethlon Medical operating expenses drop 50% in Q3 2024 - Medical Buyer
Earnings call transcript: Aethlon Medical Q4 2024 sees cost cuts, stock rises - Investing.com Nigeria
Aethlon Medical Reports Q3 Results and Corporate Update - TipRanks
Aethlon Medical Inc. (AEMD) reports earnings - Quartz
Aethlon Medical Achieves Milestone in Oncology Trials - TipRanks
Aethlon's Hemopurifier Cancer Trial Milestone Achieved as Q3 Expenses Drop 50% - StockTitan
0.85%
0.22%
자본화:
|
볼륨(24시간):